Supporting the designation of September 2026 as "National Ovarian Cancer Awareness Month".
The source supplies the latest action, but no lifecycle stage.
Latest action (24 Sep 2026): Referred to the House Committee on Oversight and Government Reform.
What this bill does
This resolution, H.Res. 1578, would express support for designating September 2026 as "National Ovarian Cancer Awareness Month." The resolution notes that ovarian cancer is a leading cause of cancer deaths for women in the U.S. and that there is no reliable early detection test. It also highlights challenges in diagnosis and treatment faced by certain demographic groups.
The resolution is sponsored by Representative Rosa DeLauro and co-sponsored by Representative Don Bacon. It affects the general public by aiming to increase awareness of ovarian cancer, its symptoms, and the importance of early detection and research. It also touches upon disparities in healthcare access and outcomes for women, including Black women, low-income women, and women in rural areas.
H.Res. 1578 was introduced in the House of Representatives on September 24, 2026, and was referred to the Committee on Oversight and Government Reform. As a resolution, it expresses the sentiment of the House but does not require presidential signature to become law. If passed by the House, its next step would be to proceed through the legislative process within the House.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
24 Sep 2026
Referred to the House Committee on Oversight and Government Reform.
Common questions
- What does H.Res. 1578 do?
- This resolution, H.Res. 1578, would express support for designating September 2026 as "National Ovarian Cancer Awareness Month." The resolution notes that ovarian cancer is a leading cause of cancer deaths for women in the U.S. and that there is no reliable early detection test. It also highlights challenges in diagnosis and treatment faced by certain demographic groups. The resolution is sponsored by Representative Rosa DeLauro and co-sponsored by Representative Don Bacon. It affects the general public by aiming to increase awareness of ovarian cancer, its symptoms, and the importance of early detection and research. It also touches upon disparities in healthcare access and outcomes for women, including Black women, low-income women, and women in rural areas. H.Res. 1578 was introduced in the House of Representatives on September 24, 2026, and was referred to the Committee on Oversight and Government Reform. As a resolution, it expresses the sentiment of the House but does not require presidential signature to become law. If passed by the House, its next step would be to proceed through the legislative process within the House.
- Has H.Res. 1578 become law?
- The source does not supply a confirmed lifecycle stage for H.Res. 1578. Check the latest action and official source below.
- Who sponsored H.Res. 1578?
- H.Res. 1578 was sponsored by Rep. DeLauro, Rosa L. [D-CT-3] (D-CT), with 1 cosponsor.
- What's the latest action on H.Res. 1578?
- Referred to the House Committee on Oversight and Government Reform. (24 Sep 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. DeLauro, Rosa L. [D-CT-3]
Ovarian Cancer IMPACT Act
Calling for a trade policy that supports workers, consumers, independent farmers, small businesses, and the environment.
We Need Eviction Data Now Act of 2021
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.